Tempest Therapeutics Inc
F:3OS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tempest Therapeutics Inc
F:3OS
|
US |
Tempest Therapeutics Inc
Tempest Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines for cancer. Its main work is to discover and test small-molecule drugs that are designed to change how tumors grow, survive, and interact with the immune system. The company does not sell a broad line of products; its business is built around advancing a small number of drug candidates through clinical trials. The company’s customers are not patients directly. Instead, it works with hospitals, doctors, research sites, regulators, and eventually larger drugmakers that may license, partner on, or buy its programs. Tempest makes money, when it succeeds, through collaboration payments, licensing deals, and other commercialization arrangements tied to its drug pipeline rather than from routine product sales. What makes Tempest different is its role as an early-stage drug developer in a very high-risk part of the healthcare industry. It focuses on finding cancer treatments with novel biological targets and moving them through the long testing process that determines whether a drug can become an approved therapy. In practice, Tempest is a research and development company whose value depends on the progress of its experimental medicines.
Tempest Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines for cancer. Its main work is to discover and test small-molecule drugs that are designed to change how tumors grow, survive, and interact with the immune system. The company does not sell a broad line of products; its business is built around advancing a small number of drug candidates through clinical trials.
The company’s customers are not patients directly. Instead, it works with hospitals, doctors, research sites, regulators, and eventually larger drugmakers that may license, partner on, or buy its programs. Tempest makes money, when it succeeds, through collaboration payments, licensing deals, and other commercialization arrangements tied to its drug pipeline rather than from routine product sales.
What makes Tempest different is its role as an early-stage drug developer in a very high-risk part of the healthcare industry. It focuses on finding cancer treatments with novel biological targets and moving them through the long testing process that determines whether a drug can become an approved therapy. In practice, Tempest is a research and development company whose value depends on the progress of its experimental medicines.
